ARS Pharmaceuticals, Inc. (SPRY)
5.89
-0.14
(-2.32%)
USD |
NASDAQ |
Aug 28, 16:00
5.89
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals Total Assets (Quarterly) : 249.50M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 249.50M |
| March 31, 2026 | 287.57M |
| December 31, 2025 | 327.65M |
| September 30, 2025 | 372.80M |
| June 30, 2025 | 313.47M |
| March 31, 2025 | 327.32M |
| December 31, 2024 | 351.15M |
| September 30, 2024 | 217.60M |
| June 30, 2024 | 221.97M |
| March 31, 2024 | 227.58M |
| December 31, 2023 | 233.19M |
| September 30, 2023 | 248.56M |
| June 30, 2023 | 258.75M |
| March 31, 2023 | 271.19M |
| Date | Value |
|---|---|
| December 31, 2022 | 281.44M |
| September 30, 2022 | 271.06M |
| June 30, 2022 | 294.00M |
| March 31, 2022 | 312.47M |
| December 31, 2021 | 61.45M |
| September 30, 2021 | 352.56M |
| June 30, 2021 | 366.98M |
| March 31, 2021 | 382.20M |
| December 31, 2020 | 394.80M |
| September 30, 2020 | 148.91M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 15.65M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Passage Bio, Inc. | 25.18M |
| Vertex Pharmaceuticals, Inc. | 27.42B |
| Capricor Therapeutics, Inc. | 368.74M |
| Kyntra Bio, Inc. | 101.08M |
| Zentalis Pharmaceuticals, Inc. | 215.33M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 236.98M |
| Shareholders Equity (Quarterly) | 12.51M |
| Debt to Equity Ratio | 7.727 |
| Current Ratio | 3.475 |
| Net Debt Paydown Yield | -2.43% |